Neumora Therapeutics named Joshua Pinto CEO and board member, replacing Paul Berns as CEO. Berns will become executive chair. The leadership change was announce

BWB News TV • 2026-08-14 11:16 UTC • By Billy Odell Tucker-Robinson

Neumora Therapeutics named Joshua Pinto CEO and board member, replacing Paul Berns as CEO. Berns will become executive chair. The leadership change was announced alongside Q2 2026 results, with no additional financial details.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly